A top orthopaedic surgeon and former NSW Australian of the year has argued in his defamation case against Nine that stories detailing his alleged negligence misled the public about medical issues and were the “opposite of public interest” journalism.
Former SAS soldier Ben Roberts-Smith should pay all costs reasonably incurred by Fairfax in successfully defending itself in his defamation case, which took more than 100 trial days and was an abuse of process, a court has heard.
A Melbourne lawyer has been found guilty of two counts of contempt of court for failing to share logins and passwords to his firm’s computer records to an auditor appointed by Victoria’s legal watchdog.
Agrochemical giant Monsanto is digging in for a fight in a class action over its alleged carcinogenic weed killer, Roundup, having refused to budge in mediation despite a $16 billion settlement in the US.
A solar cell patent at the heart of intellectual property litigation brought by South Korean technology giant Hanwha has been found invalid.
Two former Ferrier Hodgson partners had conflicts of interest when they accepted appointments as administrators of a failed pig farm operation, an appeals court has found, but their remuneration won’t take a hit as a result.
Westpac has settled its claims against the father of Forum Finance director Vince Tesoriero, who along with fellow director Bill Papas is accused of perpetrating a $400 million fraud against the bank to fund their lavish lifestyles.
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.
ASIC wants to re-run its case against investment group M101 Nominees and founder James Mawhinney after admitting it made errors at its initial trial, arguing for new fines and disqualification orders on remittal by the Full Court, a judge has heard.
A judge has endorsed Medibank’s bid to sue the OAIC so the court can weigh in on the health insurer’s bid to halt the regulator’s investigation in favour of a class action over its October data breach, saying the OAIC’s interference with the court proceedings could constitute a contempt of court.